enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Pertuzumab - Wikipedia

    en.wikipedia.org/wiki/Pertuzumab

    Pertuzumab is administered as an intravenous infusion in combination with trastuzumab and docetaxel as a first line treatment for HER2-positive metastatic breast cancer. [4] [3] It is also used in the same combination as a neoadjuvant (given to reduce the size of a tumor, prior to surgery or radiation) for HER2-positive early breast cancer; as of 2016 this use had not been shown to increase ...

  3. Pertuzumab/trastuzumab/hyaluronidase - Wikipedia

    en.wikipedia.org/wiki/Pertuzumab/trastuzumab/...

    The fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase was approved for medical use in the United States in June 2020. [5] [10]The FDA's approval was based on the results of a non-inferiority study in participants with HER2-positive early breast cancer, which demonstrated the fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase had comparable efficacy and ...

  4. Roche's New Perjeta Combo Meets Goal in Breast Cancer Study - AOL

    www.aol.com/news/roches-perjeta-combo-meets-goal...

    Roche's (RHHBY) new fixed-dose combination of Perjeta and Herceptin meets the primary endpoint in the phase III study for treating patients with HER2-positive early breast cancer.

  5. Roche's SC Formulation of Perjeta-Herceptin Combo Gets ... - AOL

    www.aol.com/news/roches-sc-formulation-perjeta...

    Roche (RHHBY) receives FDA approval for a fixed-dose combination of Perjeta and Herceptin, Phesgo, plus chemotherapy as a treatment for HER2-positive breast cancer.

  6. FDA Advisory Committee Recommends Accelerated Approval of ...

    www.aol.com/news/2013-09-12-fda-advisory...

    FDA Advisory Committee Recommends Accelerated Approval of Genentech's Perjeta for Neoadjuvant Use in HER2-Positive Early Stage Breast Cancer The FDA Will Make a Final Decision by October 31 The ...

  7. Universal Immunisation Programme - Wikipedia

    en.wikipedia.org/wiki/Universal_Immunisation...

    Universal Immunisation Programme (UIP) is a vaccination programme launched by the Government of India in 1985. [1] It became a part of Child Survival and Safe Motherhood Programme in 1992 and is currently one of the key areas under the National Health Mission since 2005.

  8. FDA Grants Genentech's Perjeta Accelerated Approval for ... - AOL

    www.aol.com/news/2013-09-30-fda-grants-genen...

    FDA Grants Genentech's Perjeta Accelerated Approval for Use Before Surgery in People With HER2-Positive Early Stage Breast Cancer The Perjeta regimen is the first treatment approved under a new ...

  9. List of schemes of the government of India - Wikipedia

    en.wikipedia.org/wiki/List_of_schemes_of_the...

    An example given was the Right of Children to Free and Compulsory Education Act, 2009, a shortage of both schools and teachers. [167] Since their inception, flagship welfare schemes of the Modi government such as Namami Gange and Ayushman Bharat have been sanctioned more than what has been spent. [ 168 ]